Janux Therapeutics (JANX) Initiated at Outperform at Wedbush, Co's Approach has "High Likelihood of Success"
Tweet Send to a Friend
(Updated - April 5, 2023 4:18 PM EDT)
Wedbush analyst Robert Driscoll initiates coverage on Janux Therapeutics (NASDAQ ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Wedbush analyst Robert Driscoll initiates coverage on Janux Therapeutics (NASDAQ ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
